Literature DB >> 17540859

Cysteine pairs in the third intracellular loop of the muscarinic m1 acetylcholine receptor play a role in agonist-induced internalization.

Gregory W Sawyer1, Frederick J Ehlert, Crystal A Shults.   

Abstract

We determined the functional role of a small domain in the third intracellular loop of the human muscarinic M(1) (hM(1)) receptor. Using site-directed mutagenesis, several mutant hM(1) receptors were made possessing either a deletion or point mutations within the third intracellular loop domain (252)PETPPGRCCRCC(263). Wild-type and mutant hM(1) receptors were transiently expressed in Chinese hamster ovary cells, and the effects of each mutation on radioligand binding, agonist-mediated phosphoinositide hydrolysis, and agonist-induced internalization were determined. The mutant receptors exhibited a modest reduction in affinity for [(3)H]N-methylscopolamine (pK(D) = approximately 9.0) and a moderately increased binding capacity relative to the wild-type receptor. This moderate increase in binding capacity was associated with small increases in the maximal response and potency of carbachol for eliciting phosphoinositide hydrolysis through the mutant receptors (pEC(50) = approximately 5.5) relative to wild-type (pEC(50) = 5.35 +/- 0.05). In contrast, carbachol-induced internalization of mutant hM(1) receptors possessing either C259A/C260A or C262A/C263A or both double point mutations was significantly reduced compared to the wild-type hM(1) receptor. Of the hM(1) receptor mutants tested, those possessing a C262D/C263D double point mutation had the least carbachol-induced internalization. The desensitization and down-regulation of receptors possessing either Cys/Ala or Cys/Asp double point mutations were similar to those observed for the wild-type hM(1) receptor. Collectively, these observations suggest that Cys pairs Cys259/Cys260 and Cys262/Cys263 play an important role in the agonist-induced internalization of hM(1) receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17540859     DOI: 10.1124/jpet.107.123695

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  2 in total

1.  FRET-based detection of M1 muscarinic acetylcholine receptor activation by orthosteric and allosteric agonists.

Authors:  Danijela Markovic; Jonathan Holdich; Suleiman Al-Sabah; Rajendra Mistry; Cornelius Krasel; Martyn P Mahaut-Smith; R A John Challiss
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

2.  Applications and limitations of fitting of the operational model to determine relative efficacies of agonists.

Authors:  Jan Jakubík; Alena Randáková; Vladimír Rudajev; Pavel Zimčík; Esam E El-Fakahany; Vladimír Doležal
Journal:  Sci Rep       Date:  2019-03-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.